$CVM
CEL SCI CORP Stock $cvm

$cvm Overview Financials Valuation SEC Filings Company Website

2024 Q3 Form 10-Q Financial Statement

#000165495424010651 Filed on August 14, 2024

Income Statement

Concept	2024 Q3	2024 Q2
Revenue		$0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin		$1.967M
YoY Change		-19.84%
% of Gross Profit
Research & Development		$4.703M
YoY Change		-17.89%
% of Gross Profit
Depreciation & Amortization		$984.2K
YoY Change		-0.15%
% of Gross Profit
Operating Expenses		$6.670M
YoY Change		-18.47%
Operating Profit		-$6.670M
YoY Change		-18.47%
Interest Expense		-$190.7K
YoY Change		4.97%
% of Operating Profit
Other Income/Expense, Net		$4.380K
YoY Change		-213.77%
Pretax Income		-$6.857M
YoY Change		-18.06%
Income Tax
% Of Pretax Income
Net Earnings		-$6.857M
YoY Change		-18.06%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share		-$0.14
COMMON SHARES
Basic Shares Outstanding	61.49M shares	54.16M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2024 Q3	2024 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments		$435.8K
YoY Change		-91.55%
Cash & Equivalents		$384.7K
Short-Term Investments		$51.13K
Other Short-Term Assets		$551.3K
YoY Change		19.12%
Inventory		$2.555M
Prepaid Expenses		$551.3K
Receivables
Other Receivables
Total Short-Term Assets		$3.542M
YoY Change		-54.18%
LONG-TERM ASSETS
Property, Plant & Equipment		$8.613M
YoY Change		-19.31%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets		$2.391M
YoY Change		-0.37%
Total Long-Term Assets		$20.53M
YoY Change		-16.52%
TOTAL ASSETS
Total Short-Term Assets		$3.542M
Total Long-Term Assets		$20.53M
Total Assets		$24.07M
YoY Change		-25.53%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable		$1.369M
YoY Change		-21.42%
Accrued Expenses		$1.272M
YoY Change		11.47%
Deferred Revenue
YoY Change
Short-Term Debt		$0.00
YoY Change
Long-Term Debt Due		$1.949M
YoY Change		13.46%
Total Short-Term Liabilities		$5.506M
YoY Change		4.04%
LONG-TERM LIABILITIES
Long-Term Debt		$8.478M
YoY Change		-18.54%
Other Long-Term Liabilities		$125.0K
YoY Change		0.0%
Total Long-Term Liabilities		$125.0K
YoY Change		0.0%
TOTAL LIABILITIES
Total Short-Term Liabilities		$5.506M
Total Long-Term Liabilities		$125.0K
Total Liabilities		$15.60M
YoY Change		-11.03%
SHAREHOLDERS EQUITY
Retained Earnings		-$507.9M
YoY Change		5.93%
Common Stock		$542.6K
YoY Change		21.25%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity		$8.473M
YoY Change
Total Liabilities & Shareholders Equity		$24.07M
YoY Change		-25.53%

Cashflow Statement

Concept	2024 Q3	2024 Q2
OPERATING ACTIVITIES
Net Income		-$6.857M
YoY Change		-18.06%
Depreciation, Depletion And Amortization		$984.2K
YoY Change		-0.15%
Cash From Operating Activities		-$4.579M
YoY Change		-19.19%
INVESTING ACTIVITIES
Capital Expenditures		$23.47K
YoY Change		-88.08%
Acquisitions
YoY Change
Other Investing Activities		$0.00
YoY Change
Cash From Investing Activities		-$23.47K
YoY Change		-88.08%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities		-322.3K
YoY Change		-133.87%
NET CHANGE
Cash From Operating Activities		-4.579M
Cash From Investing Activities		-23.47K
Cash From Financing Activities		-322.3K
Net Change In Cash		-4.925M
YoY Change		0.27%
FREE CASH FLOW
Cash From Operating Activities		-$4.579M
Capital Expenditures		$23.47K
Free Cash Flow		-$4.602M
YoY Change		-21.5%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-8367281	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	27075	shares
CY2024Q1	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	2
CY2024Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	7000000	usd
CY2024Q1	cvm	Netofissuance Costs NetofissuanceCosts	700000	usd
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	2490000	shares
CY2023Q4	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	2.00
CY2023Q4	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	4500000	usd
CY2023Q4	cvm	Netofissuance Costs NetofissuanceCosts	500000	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	1967500	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	6500	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	293000	shares
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	1964500	shares
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	240000	shares
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	57500	shares
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	40	shares
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	13383000	shares
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	260000	usd
	cvm	Equity Warrants Exercised EquityWarrantsExercised	217752	shares
	cvm	Proceeds From Equity Warrants Exercised ProceedsFromEquityWarrantsExercised	447291	usd
CY2024Q2	us-gaap	Other Research And Development Expense OtherResearchAndDevelopmentExpense	35800000	usd
	us-gaap	Interest Paid InterestPaid	700000	usd
	us-gaap	Interest Paid InterestPaid	800000	usd
CY2024Q2	us-gaap	Finance Lease Liability Payments Due Next Twelve Months FinanceLeaseLiabilityPaymentsDueNextTwelveMonths	2747000	usd
CY2024Q2	us-gaap	Finance Lease Liability Payments Due Year Two FinanceLeaseLiabilityPaymentsDueYearTwo	2838000	usd
CY2024Q2	us-gaap	Finance Lease Liability Payments Due Year Three FinanceLeaseLiabilityPaymentsDueYearThree	2929000	usd
CY2024Q2	us-gaap	Finance Lease Liability Payments Due Year Four FinanceLeaseLiabilityPaymentsDueYearFour	3021000	usd
CY2024Q2	us-gaap	Finance Lease Liability Payments Due Year Five FinanceLeaseLiabilityPaymentsDueYearFive	255000	usd
CY2024Q2	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	12456000	usd
CY2024Q2	us-gaap	Finance Lease Liability Undiscounted Excess Amount FinanceLeaseLiabilityUndiscountedExcessAmount	2029000	usd
CY2024Q2	us-gaap	Finance Lease Liability FinanceLeaseLiability	10427000	usd
CY2024Q2	cvm	Finance Lease Liability Current Portion FinanceLeaseLiabilityCurrentPortion	1949000	usd
CY2024Q2	cvm	Finance Lease Liability Noncurrent Portion FinanceLeaseLiabilityNoncurrentPortion	8478000	usd
	us-gaap	Operating Lease Payments Use OperatingLeasePaymentsUse	300000	usd
CY2024Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.1019	pure
	cvm	Operating Lease Weighted Average Remaining Lease Term One OperatingLeaseWeightedAverageRemainingLeaseTermOne	P7Y1M28D
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	90000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	366000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	287000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	277000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	285000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	294000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	746000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	640000	usd
CY2024Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	1705000	usd
CY2024Q2	cvm	Operating Lease Liability Current Portion OperatingLeaseLiabilityCurrentPortion	219000	usd
CY2024Q2	cvm	Operating Lease Liability Noncurrent Portion OperatingLeaseLiabilityNoncurrentPortion	1486000	usd
	cvm	Finite Lived Intangible Assets Remaining Amortization Period FiniteLivedIntangibleAssetsRemainingAmortizationPeriod	P8Y
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	25000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	29000	usd
CY2024Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	7000	usd
CY2023Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	9000	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	29000	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	25000	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	19000	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	16000	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Rolling After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseRollingAfterYearFive	54000	usd
CY2024Q2	us-gaap	Other Indefinite Lived Intangible Assets OtherIndefiniteLivedIntangibleAssets	173000	usd
	cvm	Net Income Loss Available To Common Stockholders Basic And Diluted NetIncomeLossAvailableToCommonStockholdersBasicAndDiluted	-21470429	usd
	cvm	Net Income Loss Available To Common Stockholders Basic And Diluted NetIncomeLossAvailableToCommonStockholdersBasicAndDiluted	-24735151	usd
CY2024Q2	cvm	Net Income Loss Available To Common Stockholders Basic And Diluted NetIncomeLossAvailableToCommonStockholdersBasicAndDiluted	-7516014	usd
CY2023Q2	cvm	Net Income Loss Available To Common Stockholders Basic And Diluted NetIncomeLossAvailableToCommonStockholdersBasicAndDiluted	-8367281	usd
	cvm	Weighted Average Number Of Share Outstanding Basics And Diluted WeightedAverageNumberOfShareOutstandingBasicsAndDiluted	51479454	shares
	cvm	Weighted Average Number Of Share Outstanding Basics And Diluted WeightedAverageNumberOfShareOutstandingBasicsAndDiluted	43761395	shares
CY2024Q2	cvm	Weighted Average Number Of Share Outstanding Basics And Diluted WeightedAverageNumberOfShareOutstandingBasicsAndDiluted	53994384	shares
	cvm	Income Loss From Continuing Operations Per Basic And Diluted Shares IncomeLossFromContinuingOperationsPerBasicAndDilutedShares	-0.42
	cvm	Income Loss From Continuing Operations Per Basic And Diluted Shares IncomeLossFromContinuingOperationsPerBasicAndDilutedShares	-0.57
CY2024Q2	cvm	Income Loss From Continuing Operations Per Basic And Diluted Shares IncomeLossFromContinuingOperationsPerBasicAndDilutedShares	-0.14
CY2023Q2	cvm	Income Loss From Continuing Operations Per Basic And Diluted Shares IncomeLossFromContinuingOperationsPerBasicAndDilutedShares	-0.19
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	17644703	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	13971615	shares
	dei	Entity Central Index Key EntityCentralIndexKey	0000725363
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--09-30
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2023Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2023Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	200000	shares
CY2023Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2024Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	600000000	shares
CY2024Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	54257884	shares
CY2023Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	47422304	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Shares Purchased For Award ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward	0	shares
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Shares Purchased For Award ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward	0	shares
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Shares Purchased For Award ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward	0	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Shares Purchased For Award ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward	0	shares
	us-gaap	Operating Lease Expense OperatingLeaseExpense	300000.0	usd
	us-gaap	Operating Lease Payments Use OperatingLeasePaymentsUse	300000.0	usd
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2024-06-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-11889
	dei	Entity Registrant Name EntityRegistrantName	CEL-SCI CORPORATION
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	CO
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	84-0916344
	dei	Entity Address Address Line1 EntityAddressAddressLine1	8229 Boone Boulevard
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 802
	dei	Entity Address City Or Town EntityAddressCityOrTown	Vienna
	dei	Entity Address State Or Province EntityAddressStateOrProvince	VA
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	22182
	dei	City Area Code CityAreaCode	703
	dei	Local Phone Number LocalPhoneNumber	506-9460
	dei	Security12b Title Security12bTitle	Common Stock
	dei	Trading Symbol TradingSymbol	CVM
	dei	Security Exchange Name SecurityExchangeName	NYSE
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2024Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	61493229	shares
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	384652	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	4145735	usd
CY2024Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	551337	usd
CY2023Q3	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	520368	usd
CY2024Q2	cvm	Supplies Used For Rd And Manufacturing Current SuppliesUsedForRDAndManufacturingCurrent	2555249	usd
CY2023Q3	cvm	Supplies Used For Rd And Manufacturing Current SuppliesUsedForRDAndManufacturingCurrent	2248072	usd
CY2024Q2	us-gaap	Deposits Assets Current DepositsAssetsCurrent	51129	usd
CY2023Q3	us-gaap	Deposits Assets Current DepositsAssetsCurrent	4245	usd
CY2024Q2	us-gaap	Assets Current AssetsCurrent	3542367	usd
CY2023Q3	us-gaap	Assets Current AssetsCurrent	6918420	usd
CY2024Q2	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	7800909	usd
CY2023Q3	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	9131987	usd
CY2024Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1548010	usd
CY2023Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1698243	usd
CY2024Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	8613316	usd
CY2023Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	10188126	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	173028	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	197704	usd
CY2024Q2	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	2319101	usd
CY2023Q3	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	2319101	usd
CY2024Q2	cvm	Supplies Used For Rd And Manufacturing Non Current SuppliesUsedForRDAndManufacturingNonCurrent	71589	usd
CY2023Q3	cvm	Supplies Used For Rd And Manufacturing Non Current SuppliesUsedForRDAndManufacturingNonCurrent	74669	usd
CY2024Q2	us-gaap	Assets Assets	24068320	usd
CY2023Q3	us-gaap	Assets Assets	30528250	usd
CY2024Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	1369441	usd
CY2023Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	2009786	usd
CY2024Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1272149	usd
CY2023Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1049581	usd
CY2024Q2	cvm	Due To Employee Current DueToEmployeeCurrent	696487	usd
CY2023Q3	cvm	Due To Employee Current DueToEmployeeCurrent	557244	usd
CY2024Q2	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	1949245	usd
CY2023Q3	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	1771804	usd
CY2024Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	219019	usd
CY2023Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	197431	usd
CY2024Q2	us-gaap	Liabilities Current LiabilitiesCurrent	5506341	usd
CY2023Q3	us-gaap	Liabilities Current LiabilitiesCurrent	5585846	usd
CY2024Q2	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	8477784	usd
CY2023Q3	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	9949565	usd
CY2024Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1486138	usd
CY2023Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1652949	usd
CY2024Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	125000	usd
CY2023Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	125000	usd
CY2024Q2	us-gaap	Liabilities Liabilities	15595263	usd
CY2023Q3	us-gaap	Liabilities Liabilities	17313360	usd
CY2024Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2024Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	200000	shares
CY2024Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2024Q2	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2023Q3	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2024Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2024Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	600000000	shares
CY2024Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	54257884	shares
CY2023Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	47422304	shares
CY2024Q2	us-gaap	Common Stock Value CommonStockValue	542578	usd
CY2023Q3	us-gaap	Common Stock Value CommonStockValue	474223	usd
CY2024Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	515832848	usd
CY2023Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	499832063	usd
CY2024Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-507902369	usd
CY2023Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-487091396	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	8473057	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	13214890	usd
CY2024Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	24068320	usd
CY2023Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	30528250	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	13684204	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	17203823	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	6547866	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	6804729	usd
	us-gaap	Operating Expenses OperatingExpenses	20232070	usd
	us-gaap	Operating Expenses OperatingExpenses	24008552	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-20232070	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-24008552	usd
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-571102	usd
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-493522	usd
	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	7801	usd
	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	61525	usd
	us-gaap	Net Income Loss NetIncomeLoss	-20810973	usd
	us-gaap	Net Income Loss NetIncomeLoss	-24563599	usd
	cvm	Modification Of Warrants ModificationOfWarrants	-659456	usd
	cvm	Modification Of Warrants ModificationOfWarrants	-171552	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-21470429	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-24735151	usd
	cvm	Earning Per Share Basic And Diluted EarningPerShareBasicAndDiluted	-0.42
	cvm	Earning Per Share Basic And Diluted EarningPerShareBasicAndDiluted	-0.57
	cvm	Weighted Average Number Of Common Shares Outstanding Basic And Diluted WeightedAverageNumberOfCommonSharesOutstandingBasicAndDiluted	51479454	shares
	cvm	Weighted Average Number Of Common Shares Outstanding Basic And Diluted WeightedAverageNumberOfCommonSharesOutstandingBasicAndDiluted	43761395	shares
CY2024Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	4703160	usd
CY2023Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	5727789	usd
CY2024Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1967075	usd
CY2023Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2453968	usd
CY2024Q2	us-gaap	Operating Expenses OperatingExpenses	6670235	usd
CY2023Q2	us-gaap	Operating Expenses OperatingExpenses	8181757	usd
CY2024Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-6670235	usd
CY2023Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-8181757	usd
CY2024Q2	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-190705	usd
CY2023Q2	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-181670	usd
CY2024Q2	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	4382	usd
CY2023Q2	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	3854	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	-6856558	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-8367281	usd
CY2024Q2	cvm	Modification Of Warrants ModificationOfWarrants	-659456	usd
CY2023Q2	cvm	Modification Of Warrants ModificationOfWarrants	0	usd
CY2024Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-7516014	usd
CY2024Q2	cvm	Earning Per Share Basic And Diluted EarningPerShareBasicAndDiluted	-0.14
CY2023Q2	cvm	Earning Per Share Basic And Diluted EarningPerShareBasicAndDiluted	-0.19
CY2024Q2	cvm	Weighted Average Number Of Common Shares Outstanding Basic And Diluted WeightedAverageNumberOfCommonSharesOutstandingBasicAndDiluted	53994384	shares
CY2023Q2	cvm	Weighted Average Number Of Common Shares Outstanding Basic And Diluted WeightedAverageNumberOfCommonSharesOutstandingBasicAndDiluted	44254363	shares
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	13214890	usd
CY2023Q4	us-gaap	Stock Issued During Period Value Employee Benefit Plan StockIssuedDuringPeriodValueEmployeeBenefitPlan	48907	usd
CY2023Q4	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	202307	usd
CY2023Q4	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	4980000	usd
CY2023Q4	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	1383909	usd
CY2023Q4	cvm	Share Issuance Costs ShareIssuanceCosts	-470229	usd
CY2023Q4	us-gaap	Net Income Loss NetIncomeLoss	-6709524	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	12650260	usd
CY2024Q1	us-gaap	Stock Issued During Period Value Employee Benefit Plan StockIssuedDuringPeriodValueEmployeeBenefitPlan	53485	usd
CY2024Q1	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	380870	usd
CY2024Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	7750000	usd
CY2024Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	1432540	usd
CY2024Q1	cvm	Share Issuance Costs ShareIssuanceCosts	-717621	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-7244891	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	14304643	usd
CY2024Q2	us-gaap	Stock Issued During Period Value Employee Benefit Plan StockIssuedDuringPeriodValueEmployeeBenefitPlan	60577	usd
CY2024Q2	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	155655	usd
CY2024Q2	cvm	Purchase Of Stock By Officers And Directors Amount PurchaseOfStockByOfficersAndDirectorsAmount	80620	usd
CY2024Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	728120	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	-6856558	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	8473057	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	32163207	usd
CY2022Q4	cvm	Warrant Exercises Amount WarrantExercisesAmount	447291	usd
CY2022Q4	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	1703931	usd
CY2022Q4	us-gaap	Stock Issued During Period Value Employee Benefit Plan StockIssuedDuringPeriodValueEmployeeBenefitPlan	50178	usd
CY2022Q4	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	91623	usd
CY2022Q4	cvm	Incentive Stock Forfeited Amount IncentiveStockForfeitedAmount	-11100	usd
CY2022Q4	us-gaap	Net Income Loss NetIncomeLoss	-7853509	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	26591621	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	1743288	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Employee Benefit Plan StockIssuedDuringPeriodValueEmployeeBenefitPlan	54865	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	100635	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-8342809	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	20147600	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	1551319	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Employee Benefit Plan StockIssuedDuringPeriodValueEmployeeBenefitPlan	52663	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	135669	usd
CY2023Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	1552497	usd
CY2023Q2	cvm	Incentive Stock Forfeited Amount IncentiveStockForfeitedAmount	-11100	usd
CY2023Q2	cvm	Share Issuance Costs ShareIssuanceCosts	-271968	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-8367281	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	14789399	usd
	us-gaap	Profit Loss ProfitLoss	20810973	usd
	us-gaap	Profit Loss ProfitLoss	24563599	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	2977603	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	2959681	usd
	us-gaap	Other Noncash Expense OtherNoncashExpense	5008	usd
	us-gaap	Other Noncash Expense OtherNoncashExpense	12788	usd
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	778571	usd
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	473723	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	3544569	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	4976338	usd
	cvm	Common Stock Contributed To Employee Benefit Plan CommonStockContributedToEmployeeBenefitPlan	162969	usd
	cvm	Common Stock Contributed To Employee Benefit Plan CommonStockContributedToEmployeeBenefitPlan	157706	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	15708	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-208419	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	304097	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	24491	usd
	us-gaap	Increase Decrease In Deposits IncreaseDecreaseInDeposits	-46884	usd
	us-gaap	Increase Decrease In Deposits IncreaseDecreaseInDeposits	-2342951	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-592370	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	66616	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	167568	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	243800	usd
	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	139243	usd
	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	28173	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-13994502	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-17803797	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	75122	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	361892	usd
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	13211	usd
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	0	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-88333	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-361892	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	12730000	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	1552497	usd
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	1173577	usd
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	213796	usd
	us-gaap	Increase Decrease Due From Officers And Stockholders IncreaseDecreaseDueFromOfficersAndStockholders	-80620	usd
	us-gaap	Increase Decrease Due From Officers And Stockholders IncreaseDecreaseDueFromOfficersAndStockholders	0	usd
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	0	usd
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	447291	usd
	us-gaap	Repayments Of Debt And Capital Lease Obligations RepaymentsOfDebtAndCapitalLeaseObligations	1315291	usd
	us-gaap	Repayments Of Debt And Capital Lease Obligations RepaymentsOfDebtAndCapitalLeaseObligations	1157371	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	10321752	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	628621	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-3761083	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-17537068	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	4145735	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	22672138	usd
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	384652	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	5135070	usd
	cvm	Assets Purchased Under Finance Leases AssetsPurchasedUnderFinanceLeases	20797	usd
	cvm	Assets Purchased Under Finance Leases AssetsPurchasedUnderFinanceLeases	0	usd
	cvm	Finance Lease Obligation Included In Accounts Payable FinanceLeaseObligationIncludedInAccountsPayable	1296	usd
	cvm	Finance Lease Obligation Included In Accounts Payable FinanceLeaseObligationIncludedInAccountsPayable	927	usd
	cvm	Property And Equipment Purchases Included In Current Liabilities PropertyAndEquipmentPurchasesIncludedInCurrentLiabilities	2770	usd
	cvm	Property And Equipment Purchases Included In Current Liabilities PropertyAndEquipmentPurchasesIncludedInCurrentLiabilities	0	usd
	cvm	Consulting Services Paid With Issuance Of Common Stock ConsultingServicesPaidWithIssuanceOfCommonStock	738832	usd
	cvm	Consulting Services Paid With Issuance Of Common Stock ConsultingServicesPaidWithIssuanceOfCommonStock	327927	usd
	cvm	Accrued Consulting Services To Be Paid With Common Stock AccruedConsultingServicesToBePaidWithCommonStock	110000	usd
	cvm	Accrued Consulting Services To Be Paid With Common Stock AccruedConsultingServicesToBePaidWithCommonStock	110000	usd
	cvm	Financing Costs Included In Current Liabilities FinancingCostsIncludedInCurrentLiabilities	91975	usd
	cvm	Financing Costs Included In Current Liabilities FinancingCostsIncludedInCurrentLiabilities	58172	usd
	us-gaap	Interest Paid Net InterestPaidNet	706517	usd
	us-gaap	Interest Paid Net InterestPaidNet	809495	usd
	cvm	Impairment Of Long Lived Assets Policy Textblock ImpairmentOfLongLivedAssetsPolicyTextblock	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0.25in; text-align:justify;"><em>Impairment of long-lived assets</em> – CEL-SCI’s fixed assets are made up of leasehold improvements, furniture, and equipment. ASC 360-10 requires that a long-lived asset group be reviewed for impairment only when events or changes in circumstances indicate that the carrying amount of the long-lived asset (group) might not be recoverable. CEL-SCI’s recurring losses are a triggering event that could indicate impairment of long-lived assets such as fixed assets. CEL-SCI reviews these assets to determine if events or changes in circumstances indicate the existence of impairment. If indicators of impairment exist, the Company tests for recoverability, then, if necessary, measures and records the impairment. The amount of the impairment loss would be the amount by which the carrying amount of the asset (group) exceeds its fair value.</p>
	us-gaap	Use Of Estimates UseOfEstimates	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0.25in; text-align:justify;"><em>Use of Estimates</em> – The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and the accompanying disclosures. These estimates are based on management’s best knowledge of current events and actions the Company may undertake in the future. Estimates are used in accounting for, among other items, inventory obsolescence, accruals, stock options, useful lives for depreciation and amortization of long-lived assets, right of use assets and lease liabilities, deferred tax assets and the related valuation allowance. Actual results could differ from estimates, although management does not generally believe such differences would materially affect the financial statements in any given year. Additionally, in calculating the right of use assets and lease liabilities, estimates and assumptions were used to determine the incremental borrowing rates and the expected lease terms. The Company considers the estimates used in valuing the stock options and the lease assets and liabilities to be significant. </p>
CY2024Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	3875000	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	179832	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	58787	shares
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	2000	shares
	cvm	Stock Option Plan StockOptionPlan	234332	usd
CY2024Q2	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	101000	usd
CY2023Q4	cvm	Annual Increase To Interest Payments AnnualIncreaseToInterestPayments	0.03	pure
CY2024Q2	cvm	Annual Increase To Interest Payments AnnualIncreaseToInterestPayments	0.0846	pure
CY2024Q2	cvm	Operating Lease Weighted Average Remaining Lease Term One OperatingLeaseWeightedAverageRemainingLeaseTermOne	P4Y4M2D
CY2024Q2	us-gaap	Finance Lease Liability Payments Remainder Of Fiscal Year FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear	666000	usd
	us-gaap	Operating Lease Expense OperatingLeaseExpense	300000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	2345000	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	8000	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	22000	usd
CY2023Q2	cvm	Weighted Average Number Of Share Outstanding Basics And Diluted WeightedAverageNumberOfShareOutstandingBasicsAndDiluted	44254363	shares

Files In Submission

Name	View Source	Status
0001654954-24-010651-index-headers.html	Edgar Link	pending
0001654954-24-010651-index.html	Edgar Link	pending
0001654954-24-010651.txt	Edgar Link	pending
0001654954-24-010651-xbrl.zip	Edgar Link	pending
cvm-20240630.xsd	Edgar Link	pending
cvm_10q.htm	Edgar Link	pending
cvm_10qimg10.jpg	Edgar Link	pending
cvm_10qimg11.jpg	Edgar Link	pending
cvm_10qimg12.jpg	Edgar Link	pending
cvm_10qimg13.jpg	Edgar Link	pending
cvm_10qimg14.jpg	Edgar Link	pending
cvm_10qimg15.jpg	Edgar Link	pending
cvm_10qimg8.jpg	Edgar Link	pending
cvm_10qimg9.jpg	Edgar Link	pending
cvm_ex31.htm	Edgar Link	pending
cvm_ex32.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
cvm-20240630_def.xml	Edgar Link	unprocessable
cvm-20240630_lab.xml	Edgar Link	unprocessable
cvm-20240630_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
cvm_10q_htm.xml	Edgar Link	completed
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
cvm-20240630_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CVM
CEL SCI CORP Stock $cvm

2024 Q3 Form 10-Q Financial Statement

#000165495424010651 Filed on August 14, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CVM CEL SCI CORP Stock $cvm

2024 Q3 Form 10-Q Financial Statement

#000165495424010651 Filed on August 14, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CVM
CEL SCI CORP Stock $cvm